MONTREAL, October 12, 2023 — Paraza Pharma, a Montreal-based, fully integrated drug discovery company whose mission is to provide a seamless, innovative, and cost-effective approach to drug discovery, announces its partnership with Mila, the world’s largest academic deep learning research center.
Paraza is committed to providing its clients with innovative and effective drug discovery services and has been at the forefront of incorporating novel approaches and technologies, including the practical implementation of artificial intelligence (AI) in its drug discovery processes.
“Paraza is excited to be a leader in the effort to translate breakthroughs in deep learning technology to practical applications in the life sciences. Although there has been much AI hype and corresponding AI skepticism in the drug discovery space, our belief is that our clients, and ultimately society at large, stand to gain from the more concrete benefits for which computational approaches are promising: improvement in drug-like properties, decreased cycle times, and chemical diversity of therapeutics, among others. Being in close proximity allows for close collaboration, and Mila will play a significant role in Paraza’s broader effort toward the integration of AI in drug discovery,” said Aazer Siddiqui, Chief Strategy & Corporate Development Officer at Paraza.
“Mila is pleased to welcome Paraza as a new partner in its community. We believe that AI can be an important part of novel drug discovery, and Paraza’s broad commercial services work combined with Mila’s academic expertise can lead to great advancements toward our goal of benefiting society,” said Laurent Tillement, Director of AI and Health Partnerships at Mila.
About Paraza Pharma
Paraza Pharma is a Montreal, Canada based, fully integrated drug discovery organization passionately committed to contribute to the life sciences sector. As part of its growth strategy, it attracts worldwide best-in-class talent and continues to offer a unique collaborative model to help companies achieve their success milestones and accelerate their business growth. Learn more at parazapharma.com.
Founded by Professor Yoshua Bengio of the University of Montreal, Mila is an artificial intelligence research institute that brings together over 1,200 researchers specializing in machine learning. Based in Montreal, Mila’s mission is to be a global hub for scientific advances that inspire innovation and development of AI for the benefit of all. Mila is a non-profit organization recognized worldwide for its significant contributions to the field of deep learning, particularly in language modeling, machine translation, object recognition, and generative models. For more information, visit mila.quebec.